The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach

Update Magazine | December 2018/January 2019

The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach2019-03-01T10:14:17-05:00

JUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers?

Update Magazine | December 2018/January 2019

JUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers?2019-03-01T10:20:19-05:00

A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?

Update Magazine | December 2018/January 2019

A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?2019-03-01T10:18:58-05:00

Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity

Update Magazine | December 2018/January 2019

Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity2019-03-01T10:19:31-05:00

Spotlight on Tobacco | Future Developments in the Regulation of Electronic Nicotine Delivery Systems: Potential Over-the-Counter Pathway

Update Magazine | October/November 2018

Spotlight on Tobacco | Future Developments in the Regulation of Electronic Nicotine Delivery Systems: Potential Over-the-Counter Pathway2018-11-30T11:51:22-05:00

Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?

Update Magazine | October/November 2018

Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?2018-12-04T10:17:20-05:00

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products

Update Magazine | October/November 2018

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products2018-11-30T11:51:23-05:00
Go to Top